Your browser doesn't support javascript.
loading
Emicizumab for acquired haemophilia A: A case series.
Engelen, Matthias M; Vandesande, Johan; De Bent, Johan; Van Laer, Christine; Labarque, Veerle; Jacquemin, Marc; Peerlinck, Kathelijne; Hermans, Cedric; Verhamme, Peter; Vanassche, Thomas.
Affiliation
  • Engelen MM; Hemophilia Center, University Hospitals Leuven, Leuven, Belgium.
  • Vandesande J; Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
  • De Bent J; Hemophilia Center, University Hospitals Leuven, Leuven, Belgium.
  • Van Laer C; Hemophilia Center, University Hospitals Leuven, Leuven, Belgium.
  • Labarque V; Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
  • Jacquemin M; Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Peerlinck K; Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
  • Hermans C; Department of Pediatric Hemato-Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Verhamme P; Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
  • Vanassche T; Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
Haemophilia ; 29(4): 1049-1055, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37276345

Full text: 1 Database: MEDLINE Main subject: Antibodies, Bispecific / Hemophilia A Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Animals / Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Antibodies, Bispecific / Hemophilia A Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Animals / Humans Language: En Year: 2023 Type: Article